On August 7, 2025, Humacyte was noted to be underperforming the losses of the broader medical sector, with its stock performance lagging the S&P 500's daily gains.
2 reports, 1 independent
Updated Aug 7
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
On August 7, 2025, Humacyte was noted to be underperforming the losses of the broader medical sector, with its stock performance lagging the S&P 500's daily gains.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Humacyte (United States)
company in Morrisville, United States
Nothing else this week.
Coverage
Newest first; wire copies grouped- ZacksHumacyte, Inc. (HUMA) Stock Dips While Market Gains: Key Facts Humacyte, Inc. (HUMA) closed the most recent trading day at $2.21, moving -4.33% from the previous trading session. This change lagged t
- ZacksHumacyte, Inc. (HUMA) Stock Declines While Market Improves: Some Information for Investors Humacyte, Inc. (HUMA) closed at $2.54 in the latest trading session, marking a -1.17% move from the prior da